The CARMA3-Bcl10-MALT1 Signalosome Promotes Angiotensin II-dependent Vascular Inflammation and Atherogenesis
Open Access
- 1 August 2010
- journal article
- Published by Elsevier BV
- Vol. 285 (34), 25880-25884
- https://doi.org/10.1074/jbc.c110.109421
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The role of chemokines in recruitment of immune cells to the artery wall and adipose tissueVascular Pharmacology, 2009
- Biomarkers of AAA progression. Part 1: extracellular matrix degenerationNature Reviews Cardiology, 2009
- CD154 and its receptors in inflammatory vascular pathologiesTrends in Immunology, 2009
- CARMA1‐mediated NF‐κB and JNK activation in lymphocytesImmunological Reviews, 2009
- Role of bone marrow renin–angiotensin system in the pathogenesis of atherosclerosisPharmacology & Therapeutics, 2008
- Oncogenic CARD11 Mutations in Human Diffuse Large B Cell LymphomaScience, 2008
- The proteolytic activity of the paracaspase MALT1 is key in T cell activationNature Immunology, 2008
- Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk PredictionClinical Chemistry, 2008
- Bcl10 activates the NF-κB pathway through ubiquitination of NEMONature, 2003
- Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E–deficient miceJCI Insight, 2000